Provider review
RegenCen states in writing why it refuses to touch the research-use market, and publishes its operator under a management-company name that shares nothing with the brand. It publishes no prices at all.
Disclosure score, 6 checks
Best fora reader who wants a clinic to state its sourcing position in writing
RegenCen does not publish a price today.
RegenCen also sells 5 compounds this site boards without publishing a price for them: NAD+, Sermorelin, Ipamorelin (board ranks no provider), BPC-157 (board ranks no provider) and GHK-Cu.
What RegenCen states on its own site about leaving, getting money back, and what delivery costs. Read on September 2026.
Whether RegenCen charges to belong, on top of what it charges for the medication. Read on September 2026.
Whether RegenCen identifies the clinician or medical practice behind the prescription, or describes them only as a group. Read on September 2026.
RegenCen is not a paid partner; this link may earn a commission if that changes. Full disclosure.
On its peptide-therapy page, RegenCen argues that compounds sold for research purposes only are simply unproven, and says others have been explicitly prohibited from human use by the FDA.
That is RegenCen's claim in RegenCen's own words, and the page attaches no source to it.
The value to you is that the clinic commits to a sourcing position in public. Most sellers in this category stay silent, which leaves you nothing to hold them to later.
The about page names a management company whose name shares no words with the brand, and nothing on the page explains the relationship.
It is still a disclosure, and a better one than the silence common across this market. The company is published; it is just published under a name nobody would think to look for.
If you are checking licenses, filings or complaints, run the management-company name rather than the brand. Search the brand and the results come back empty for the wrong reason.
RegenCen names NAD+, sermorelin, ipamorelin, BPC-157 and GHK-Cu across its treatment pages, and gives peptide therapy a page of its own rather than a footnote on the IV line.
None of its six pages carries a figure for any of the five. Cost gets settled after contact, in a consult, with no range to anchor against beforehand.
If you are comparing sellers on price, there is nothing here to work with. What this clinic publishes is about approach and sourcing, not money.
No list of states appears on the site, so eligibility gets decided during intake rather than checked by you beforehand.
The facility that compounds or dispenses is never named. You have no pharmacy to look up before agreeing to a course.
No lab work is described as included in what the clinic charges, so assume any panel is billed separately and confirm it in the consult.
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.
Read the full Trellis Vitality review
Trellis Vitality is not a paid partner; this link may earn a commission if that changes. Full disclosure.
Visit Trellis VitalityIts peptide-therapy page calls compounds sold for research purposes only unproven, and says some have been explicitly prohibited from human use by the FDA. That is the clinic's claim, with no source attached.
A management company named on the about page. Its name shares no words with the brand, so search that name rather than the brand when you check filings.
Five: NAD+, sermorelin, ipamorelin, BPC-157 and GHK-Cu.
No. None of its six pages carries a figure, so cost is settled in the consult.
RegenCen is not a paid partner; this link may earn a commission if that changes. Full disclosure.